[Degree of malignancy in multiple sclerosis: clinicopathologic mortality study].

Area of Science:

• Neuropathology
• Neuroimmunology
• Clinical Neurology

Context:

• Multiple Sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
• Understanding disease progression and its neuropathologic underpinnings is crucial for patient management.
• Previous studies have explored MS pathology, but correlating specific neuropathologic findings with long-term outcomes requires further investigation.

Purpose:

• To correlate neuropathologic findings, including demyelination patterns, with disease duration, working capacity, and disability in multiple sclerosis (MS) patients.
• To evaluate the relationship between disease progression, malignancy index, and clinical outcomes.
• To investigate potential sex-based differences in MS disease course and neuropathology.

Summary:

• This study analyzed neuropathologic findings in 58 multiple sclerosis (MS) cases, categorizing lesions as acute, subacute, or chronic demyelination.
• A significant proportion of patients (48.3%) exhibited acute exacerbations in the final illness phase, associated with a heightened malignancy index.
• Neuropathologic assessment revealed longer chronic demyelination stages in women, suggesting sex-specific disease trajectories.

Impact:

• The findings provide a deeper understanding of MS neuropathology and its correlation with disease progression and clinical manifestations.
• The development of a malignancy index aids in predicting disease prognosis and associated risks.
• This research can inform clinical care strategies and patient management by offering insights into disease trajectory and sex differences in MS.